Epirubicin/ethiodized-oilTumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1897卷 / 1期

关键词：

D O I：

10.1007/s40278-022-11408-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：171 / 171

相关论文

共 50 条

[21] HydroxycarbamideTumour lysis syndrome: case report
Reactions Weekly, 2023, 1974 (1) : 170 - 170
[22] VenetoclaxTumour lysis syndrome: case report
Reactions Weekly, 2022, 1889 (1) : 314 - 314
[23] VenetoclaxTumour lysis syndrome: case report
Reactions Weekly, 2021, 1873 (1) : 232 - 232
[24] CarboplatinTumour lysis syndrome: case report
Reactions Weekly, 2019, 1740 (1) : 85 - 85
[25] DoxorubicinTumour lysis syndrome: case report
Reactions Weekly, 2013, 1482 (1) : 20 - 20
[26] DasatinibTumour lysis syndrome: case report
Reactions Weekly, 2010, 1320 (1) : 19 - 19
[27] VismodegibTumour lysis syndrome: case report
Reactions Weekly, 2019, 1767 (1) : 303 - 303
[28] MethylprednisoloneTumour lysis syndrome: case report
Reactions Weekly, 2009, 1266 (1) : 23 - 23
[29] MitotaneTumour lysis syndrome: case report
Reactions Weekly, 2019, 1748 (1) : 350 - 350
[30] SunitinibTumour lysis syndrome: case report
Reactions Weekly, 2012, 1416 (1) : 41 - 41

← 1 2 3 4 5 →